Alicia Powers

Alicia Powers has a diverse work experience in the field of clinical research and strategy development. Alicia currently works as a Clinical Scientist at Celldex Therapeutics since 2023. Prior to this, they held several roles at Allucent, including Clinical Strategy Scientist II from October 2022 to March 2023, Clinical Strategy Scientist I from November 2021 to October 2022, and Clinical Strategy Development Fellow from November 2020 to October 2021. Alicia also worked as a Postdoctoral Research Associate at UNC Lineberger Comprehensive Cancer Center from August 2020 to October 2020. Alicia has a strong academic background, having worked as a PhD Candidate and Graduate Research Assistant at the University of North Carolina at Chapel Hill from August 2014 to August 2020. During their time at the university, they also took on various roles such as TIBBS Advisory Board Member from June 2018 to October 2020, Student Mentor from August 2018 to August 2020, Co-Chair of the Future Science Educators (FuSE) Career Cohort from June 2018 to August 2019, CIRTL Advisory Group member from October 2017 to June 2019, and Teaching Assistant from August 2017 to May 2018. Additionally, Alicia gained experience as a Clinical Project Management Intern at Cato Research from December 2019 to February 2020.

Alicia Powers earned their Bachelor's degree from the University of North Carolina Asheville in 2014. Alicia studied Cell and Molecular Biology, as well as Environmental Science during their time at the university. Subsequently, they pursued their Doctor of Philosophy (Ph.D.) at the University of North Carolina at Chapel Hill from 2014 to 2020, specializing in the field of Cell Biology and Physiology.